Literature DB >> 2478133

Multiple neuropeptides mobilise calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin.

P J Woll1, E Rozengurt.   

Abstract

The neuropeptides vasopressin, bradykinin, cholecystokinin, galanin, neurotensin and gastrin-releasing peptide stimulate rapid, transient increases in cytosolic Ca2+ in small cell lung cancer cell lines at nanomolar concentrations. Responsiveness to individual peptides is heterogeneous among the diverse cell lines, but the ability to respond to regulatory peptides is a general phenomenon. Peptide responses demonstrate homologous desensitisation and are blocked by ligand-specific antagonists, indicating that they are mediated by distinct receptors. Many neuropeptides are also secreted by small cell lung cancer. Here we suggest that multiple autocrine and paracrine interactions regulate its growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478133     DOI: 10.1016/0006-291x(89)91683-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

2.  Antidiuretic hormone acts via V1 receptors on intracellular calcium in the isolated perfused rabbit cortical thick ascending limb.

Authors:  R Nitschke; U Fröbe; R Greger
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

3.  Electrophysiological studies of the cholecystokininA receptor antagonists SR27897B and PD140548 in the rat isolated nodose ganglion.

Authors:  P M Beart; E Krstew; R E Widdop
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

4.  Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes.

Authors:  Y Xu; R L Hopfner; J R McNeill; V Gopalakrishnan
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  Growth factors, antagonists and lung cancer.

Authors:  P J Woll
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 5.344

6.  Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.

Authors:  Steven H Young; Enrique Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  2010-09-16       Impact factor: 3.575

7.  Bradykinin binding sites in healthy and carcinomatous human lung.

Authors:  A Trifilieff; E Lach; P Dumont; J P Gies
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Neurotensin expression and release in human colon cancers.

Authors:  B M Evers; J Ishizuka; D H Chung; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

Review 9.  Neurohypophyseal peptides as regulators of growth and development. A review.

Authors:  D A Carter; C K Fai; D Murphy
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

10.  Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Authors:  Alison C MacKinnon; Uzma Tufail-Hanif; Mark Wheatley; Adriano G Rossi; Christopher Haslett; Michael Seckl; Tariq Sethi
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.